Archives for June 1, 2005

← 2005

Bond buyback for BioProgress

Troubled dosage form company BioProgress has taken its first action to restructure its finances in the wake of its recent problems with increasing overheads and slower trading at its US subsidiary.

Worldwide antibody market to reach $26 billion

The worldwide market for therapeutic and diagnostic monoclonal antibodies is expected to reach $26 million (€21.2 million) by 2010, buoyed on by technological advances that allow antibodies to exhibit a specified targeted attack on disease-causing...

Courtoy tablet press gets tripled output

Niro Pharma Systems unit Courtoy has improved its MODUL rotary tablet press range with the launch of the MODUL D, a double-sided version that ramps up the unit's production capabilities, writes Phil Taylor.

Upstate launches new EZ ChIP kit

Upstate group has launched a new chromatin immunoprecipitation (ChIP) product that aims to streamline and standardise routine laboratory techniques by making testing quicker, easier and more reproducible, reports Wai Lang Chu.

US pharma industry ignoring $16 billion jackpot

According to a new report, the US pharmaceutical industry is ignoring as much as $16 billion (€13 billion) in cash as the industry struggles to cope with disappointing single-digit growth, a lack of new products to replace drugs coming off patent,...

Agilent introduces industry-first GC/MS system

Agilent Technologies has introduced the industry's first GC/MS system that allows researchers to electronically download and share application methods, accelerating the transfer and method standardisation across laboratories and eliminating the need...

Oral paclitaxel starts trials in Holland

Novagali Pharma, a biopharmaceutical company developing innovative drug delivery systems, has started a Phase I clinical trial in patients with advanced cancer for its oral formulation of the cancer drug paclitaxel.